1. Ahn SH, Kim W, Jung YK, et al. Efficacy and safety of Besifovir Dipivoxil maleate compared with Tenofovir Disoproxil fumarate in treatment of chronic hepatitis B virus infection. Clin Gastroenterol Hepatol. 2019;17(9):1850–1859.e1854.
2. Al-Mahtab M, Bazinet M, Vaillant A. Safety and efficacy of nucleic acid polymers in monotherapy and combined with immunotherapy in treatment-naive Bangladeshi patients with HBeAg+ chronic hepatitis B infection. PLoS One. 2016;11(6):e0156667.
3. American Association for the Study of Liver Diseases. Simplified HCV treatment* for treatment-naive adults without cirrhosis | HCV guidance; 2020a. Retrieved 20 Dec 2021, from: https://www.hcvguidelines.org/treatment-naive/simplified-treatment.
4. American Association for the Study of Liver Diseases. Simplified HCV treatment algorithm for treatment-naive adults with compensated cirrhosis | HCV guidance; 2020b. Retrieved 20 Dec 2021, from: https://www.hcvguidelines.org/treatment-naive/simplified-treatment-compensated-cirrhosis.
5. American Association for the Study of Liver Diseases. Patients with decompensated cirrhosis | HCV guidance; 2021a. Retrieved 20 Dec 2021, from 1: https://www.hcvguidelines.org/unique-populations/decompensated-cirrhosis.